Evidence map›Paper›PMID 12134043›Full record

ArticleJournal of virology2002

Heparan sulfate mediates infection of high-neurovirulence Theiler's viruses.

Honey V Reddi, Howard L Lipton

Erratum issuedOpen access · greenAbstract readComparative Study
In one paragraph

Article in Journal of virology, 2002. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
2.8field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 46 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. L-SIGN (CD209L) and DC-SIGN (CD209) mediate transinfection of liver cells by hepatitis C virus.Proceedings of the National Academy of Sciences of the United States of America · 2004
    Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

  • Erratum issued
5 · Who and what money

Authors and funding

2 authors at 2 institutions in 1 country.

Honey V ReddiDepartment of Neurology, Evanston Hospital, Illinois 60201, USA.
Howard L Lipton
Evanston Hospital · USNorthwestern University · US

Funding

T-CELL IMMUNITY IN TMEV-INDUCED DEMYELINATIONP01NS023349 · NINDS · NORTHWESTERN UNIVERSITY AT CHICAGO · PI LIPTON, HOWARD LEE · 1986 to 2007
$8.9M
THEILERS VIRUS-INDUCED DEMYELINATING DISEASER01NS021913 · NINDS · UNIVERSITY OF ILLINOIS AT CHICAGO · PI LIPTON, HOWARD LEE · 1985 to 2010
$3.4M
NINDS NIH HHS NS 21913NINDS NIH HHS NS 23349NINDS NIH HHS P01 NS023349NINDS NIH HHS R01 NS021913
6 · The paper itself

Abstract

The mechanisms by which Theiler's murine encephalomyelitis virus (TMEV) binds and enters host cells and the molecules involved are not completely understood. In this study, we demonstrate that the high-neurovirulence TMEV GDVII virus uses the glycosaminoglycan heparan sulfate (HS) as an attachment factor that is required for efficient infection. Studies based on soluble HS-mediated inhibition of attachment and infection, removal of HS with specific enzymes, and blocking with anti-HS antibodies establish that HS mediates GDVII virus entry into mammalian cells. Data from defined proteoglycan-deficient Chinese hamster ovary mutant cells further support the role of HS in GDVII infection and indicate that the extent of sulfation is critical for infection. Neuraminidase treatment of proteoglycan-deficient cells restores permissiveness to GDVII virus, indicating that sialic acid hinders direct access of virus to the protein entry receptor. A model of the potential steps in GDVII virus entry into mammalian cells involving HS is proposed.

Indexed as

AnimalsBinding SitesCardiovirus InfectionsCell LineCell MembraneCentral Nervous SystemCHO CellsCricetinaeEncephalitis, ViralHeparan SulfateMiceModels, BiologicalMutationNeuraminidaseProteoglycansReceptors, VirusHeparan SulfateNeuraminidaseProteoglycansReceptors, Virus

Identifiers

PMID12134043
PMCPMC155119
OpenAlexW2171181141

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.